NOTRELOAD AI
  • NOTRELOAD AI
  • Stocks BUZZ.
  • #TrumpTrade
  • 24-HOUR Pass →
  • Invest ↗
Sign in Subscribe

EchoStar Stock Surges Amid SpaceX Buzz

Morgan Stanley upgrades EchoStar after SpaceX deal. Shares jump on rising spectrum value and SpaceX IPO speculation.

EchoStar Stock Surges Amid SpaceX Buzz
“Falcon Heavy Demo Mission” by Official SpaceX Photos, CC BY-NC 2.0
Already have an account? Sign in.
Featured/ 12/10/2025 · 7:35 AM
SATS
/ Don't stop with just one post.

Related↓

AT&T logo
Featured/ 10/22/2025 · 7:33 AM

AT&T Beats Expectations with Strong Customer Growth Despite Heavy Competition

AT&T surpasses analyst predictions by adding 405,000 mobile subscribers and 288,000 fiber customers in Q3 2025, driven by aggressive promotions and bundled service offerings.

/ Subscriber only
SpaceX
Featured/ 09/08/2025 · 6:55 AM

EchoStar Sells Spectrum to SpaceX for Next-Gen Starlink Direct-to-Cell

EchoStar sells its AWS-4 & H-block spectrum to SpaceX for ~$17B (cash/stock) & $2B debt interest. This powers SpaceX's next-gen Starlink Direct-to-Cell, aiming to end mobile dead zones worldwide. Boost Mobile will access the service.

/ Subscriber only
AT&T Bolsters Connectivity with $23 Billion Spectrum Acquisition from EchoStar
Featured/ 08/26/2025 · 7:09 AM

AT&T Bolsters Connectivity with $23 Billion Spectrum Acquisition from EchoStar

AT&T acquires $23 billion in low-band and mid-band spectrum from EchoStar, significantly enhancing its 5G and home internet services across the U.S., driving long-term growth, and reinforcing its leadership in advanced connectivity.

/ Subscriber only
/ Read more

Feed↓

Beyond Meat Launches Protein Drinks Amid Declining Sales
01/16/2026 · 3:30 PM

Beyond Meat Launches Protein Drinks Amid Declining Sales

Beyond Meat introduces carbonated protein drinks through its test kitchen as plant-based meat sales decline. Experts question whether the brand can successfully expand beyond meat alternatives.

/ Subscriber only
JPMorgan Sees Strong AI Demand for CoreWeave
01/16/2026 · 2:48 PM

JPMorgan Sees Strong AI Demand for CoreWeave

JPMorgan says CoreWeave’s AI demand remains very strong, driven by long-term contracts and limited compute supply, while keeping a Neutral rating.

/ Subscriber only
Genmab's Epcoritamab Trial Falls Short on Key Survival Metric
01/16/2026 · 2:37 PM

Genmab's Epcoritamab Trial Falls Short on Key Survival Metric

Genmab's Phase 3 trial for epcoritamab shows mixed results in lymphoma patients, missing its overall survival goal despite some improvements.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe